2024-04-11 08:59:30 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries: Potential Outweighs Concerns
- Teva And Alvotech: Simlandi Approval Opens New Generic market Opportunities
- Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position
- Teva and mAbxience sign global licensing agreement for oncology biosimilar candidate
- Urogen files patent suit against Teva over cancer therapy
Read the full article on Seeking Alpha
For further details see:
Teva confirms efficacy in late stage trial of its migraine treatment for adult Chinese patients